Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Infections caused by multiresistant bacteria].

Jean-Ralph Zahar1, Agnès Ferroni

  • 1Service de bactériologie, virologie, hygiène, centre hospitalier universitaire Necker-Enfants Malades, 75743 Paris Cedex 15. jean-ralph.zahar@nck.aphp.fr

La Revue Du Praticien
|September 28, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Local infection signs at the catheter-insertion site: a large prospective multicentric cohort study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Relationship between negative-pressure ICU rooms and the risk of COVID-19-associated pulmonary aspergillosis: an ancillary analysis of the COVID-ICU cohort study.

Critical care (London, England)·2026
Same author

One Health Investigation into Fatal Encephalitis Caused by Pigeon Paramyxovirus Type 1, France.

Emerging infectious diseases·2026
Same author

Effects of Antifungal Treatment in COVID-19-Associated Pulmonary Aspergillosis: A European Multicenter Cohort Study.

Chest·2026
Same author

Impact of Elexacaftor-Tezacaftor-Ivacaftor on fungal colonisation in children and adolescents with cystic fibrosis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026
Same author

Consensus on safety skills for patients with central venous catheters: a modified Delphi method.

The Journal of hospital infection·2026
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Multiresistant bacteria (MRB) cause significant nosocomial infections, with methicillin-resistant Staphylococcus aureus and extended-spectrum beta-lactamase-producing Enterobacteriaceae being major contributors. Controlling their spread requires patient screening, hygiene, and reduced antibiotic selection pressure.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Antimicrobial resistance is a growing threat, exacerbated by antibiotic selection pressure and cross-transmission.
  • Multiresistant bacteria (MRB) are implicated in 20% of hospital-acquired infections.
  • Key MRB include methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae.

Purpose of the Study:

  • To highlight the challenges in controlling the epidemic diffusion of MRB in hospitals.
  • To emphasize the need for a multi-faceted approach to combat MRB spread.

Main Methods:

  • Review of current literature on antimicrobial resistance and nosocomial infections.
  • Analysis of the prevalence and types of MRB in healthcare settings.

Related Experiment Videos

  • Discussion of control strategies including patient screening, hygiene, and antibiotic stewardship.

    • Main Results:

    • MRB are a significant cause of nosocomial infections, with MRSA and ESBL-producing Enterobacteriaceae being predominant.
    • The epidemic diffusion of these strains remains inadequately controlled in many hospitals.
    • Current control measures, while important, are insufficient on their own.

    Conclusions:

    • Effective control of MRB requires a comprehensive strategy.
    • This strategy must integrate patient screening, stringent hygiene protocols, and interventions to reduce antibiotic selection pressure.